PFF In The Media

  • Sep 14, 2026

    ILD Day 2026: Educating healthcare professionals, patients about precision medicine

    On Sept. 16, 13 organizations recognizing patients with different forms of interstitial lung disease will unite to celebrate the sixth annual ILD Day.

    Link to Article
    Source: Healio Pulmonology
  • Sep 05, 2026

    When a Cough Could Mean More

    Shortness of breath, a chronic cough and fatigue can be easy to dismiss—but they may be signs of pulmonary fibrosis. 🫁 Dr. Amy Hajari Case of the Pulmonary Fibrosis Foundation explains why recognizing symptoms and getting an early, accurate diagnosis can make a difference.

    Link to Article
    Source: Coffee with America
  • Aug 07, 2026

    Nintedanib dry powder inhalation therapy has favorable safety, tolerability in IPF

    Nintedanib dry powder inhalation in patients with idiopathic pulmonary fibrosis was “generally safe” with “a tolerability profile built for chronic use,” according to topline data from a phase 1b study.

    Link to Article
    Source: Healio Pulmonology
  • Jul 29, 2026

    9 Tips to Calm Your IPF Cough

    Most people with idiopathic pulmonary fibrosis (IPF) experience a chronic cough. It’s often the first symptom, and it may start years before you’re diagnosed. The cough is usually dry and unproductive, and it can be difficult to treat.

    Link to Article
    Source: Everyday Health
  • Jul 20, 2026

    How to Manage Sudden Breathlessness With IPF

    It can be very scary when you feel like you can’t breathe. You may feel like you’re running out of air or just can’t breathe deeply enough. Shortness of breath, called dyspnea, is a common symptom of idiopathic pulmonary fibrosis (IPF), a chronic condition in which lung tissue becomes thick and stiff.

    Link to Article
    Source: Everyday Health
  • Jul 15, 2026

    Pulmonary Fibrosis Foundation adds 2 experts to help guide its future

    The Pulmonary Fibrosis Foundation (PFF), an advocacy group dedicated to advancing care for people with pulmonary fibrosis, has added two new members to its board of directors.

    Link to Article
    Source: Pulmonary Fibrosis News
  • Jul 15, 2026

    Pulmonary fibrosis foundation adds two to board

    Chicago pulmonologist Dr. Bradford Bemiss and Detroit pulmonary disease specialist Dr. Krishna Thavarajah have been named to the board of directors of the Pulmonary Fibrosis Foundation

    Link to Article
    Source: Crain's Chicago Buisness
  • Jul 01, 2026

    Tech Can't Heal a Broken System: What Healthcare Leaders Want You to Know

    As healthcare grows more digital, leaders across medicine, nursing, informatics, and patient advocacy are asking a more fundamental question: how can new technologies strengthen care rather than complicate it?

    Link to Article
    Source: Women We Admire
  • Jun 24, 2026

    PFF Walk raises awareness about pulmonary fibrosis

    Scott traveled from Arizona to Pittsburgh for a double lung transplant and watched Talk Pittsburgh while he was at the hospital. Now this weekend, Scott and his husband Carey will be walking to raise awareness and support for pulmonary fibrosis.

    Link to Article
    Source: KDKA-TV's Talk Pittsburgh
  • May 26, 2026

    By working together, we will be able to have better therapies and a cure for PF

    If you are a patient and not participating in research, I would like to ask you why.

    Link to Article
    Source: Pulmonary Fibrosis News
  • May 12, 2026

    How to Exercise With Idiopathic Pulmonary Fibrosis

    When you have idiopathic pulmonary fibrosis (IPF), shortness of breath, chronic fatigue, and a nagging, dry cough can make exercise feel uncomfortable and even seem intimidating for some.

    Link to Article
    Source: Everyday Health
  • May 05, 2026

    Travel Tips for Idiopathic Pulmonary Fibrosis

    Traveling with idiopathic pulmonary fibrosis (IPF) may take extra planning, but it’s possible.

    Link to Article
    Source: Everyday Health
  • Mar 25, 2026

    Inhaled treprostinil lowers FVC decline in IPF at 52 weeks

    With receipt of inhaled treprostinil for 52 weeks, adults with idiopathic pulmonary fibrosis had less FVC decline compared with those receiving placebo, according to results published in The New England Journal of Medicine.

    Link to Article
    Source: Healio Pulmonology
  • Mar 14, 2026

    St. Luke’s designated as pulmonary center

    St. Luke's University Health Network has been designated as a Care Center within the Pulmonary Fibrosis Foundation's nationally recognized Care Center Network, expanding access to specialized care for people living pulmonary fibrosis and interstitial lung disease in the region.

    Link to Article
    Source: Times News
  • Mar 05, 2026

    Pulmonary Fibrosis Foundation expands national care network, strengthening access to expert lung disease care

    The Pulmonary Fibrosis Foundation’s Care Center Network has grown to include 96 sites in 40 states as part of its first expansion since 2023, marking a milestone in strengthening access to multidisciplinary care for people living with pulmonary fibrosis (PF) and interstitial lung disease (ILD).

    Link to Article
    Source: BioSpace
  • Feb 17, 2026

    Partner with PFF through advocacy and education to benefit PF community

    The third pillar of 5-year strategic plan focuses on improving patients' lives

    Link to Article
    Source: Pulmonary Fibrosis News
  • Feb 06, 2026

    Christine Ebersole, Jelani Alladin and More to Star in BROADWAY BELTS FOR PFF!

    The lineup has been revealed for the 16th annual Broadway Belts for PFF! on Monday, March 9, at SONY Hall with a simultaneous virtual livestream.

    Link to Article
    Source: Broadway World
  • Feb 03, 2026

    Q&A: FDA accepts IPF biomarker panel into qualification program

    The FDA Center for Drug Evaluation and Research has accepted a letter of intent for the first biomarker for idiopathic pulmonary fibrosis into its Biomarker Qualification Program, according to a press release.

    Link to Article
    Source: Healio Pulmonology